Reduced Fetal Movements

1. Clinical Overview

Summary

Reduced fetal movements (RFM) represents maternal perception of decreased fetal activity compared to the established individual pattern for that pregnancy. This is a critically important obstetric presentation requiring urgent same-day assessment, as RFM is the single most common antecedent symptom of stillbirth, preceding 50-70% of late stillbirths. [1,2] Unlike many screening tests, RFM represents direct maternal perception of fetal wellbeing and is a specific indicator for placental dysfunction, fetal hypoxia, and impending fetal compromise. [3]

The management paradigm has shifted from arbitrary "kick counting" thresholds to recognition of pattern change, with emphasis on immediate face-to-face assessment, cardiotocography (CTG), and low-threshold ultrasound evaluation for recurrent presentations or high-risk features. [4,5]

Key Facts

Clinical Pearls

• Pattern Recognition Over Counting: There is no evidence-based minimum number of movements; what matters is change from the individual fetal pattern. "Count to 10" kick charts increase maternal anxiety without improving perinatal outcomes and are no longer recommended. [9,10]

• No Telephone Reassurance: Women presenting with RFM must never be reassured over the phone. All reports require face-to-face assessment with auscultation/CTG. [4]

• Timing Matters: Assessment should occur within 2 hours of presentation for women ≥28 weeks gestation. Delays in assessment have been associated with adverse outcomes. [11]

• Recurrent RFM = Red Flag: Two or more episodes of RFM, even with normal investigations, mandate specialist review and enhanced surveillance with serial growth scans and umbilical artery Doppler assessment. [7,12]

• Anterior Placenta Myth: While anterior placental location may reduce maternal perception of movements in early pregnancy, it does NOT justify reassurance without full investigation in women presenting with RFM ≥28 weeks. [13]

• No "Discharge Criteria" if Abnormal CTG: Women with non-reassuring CTG patterns should never be discharged without senior obstetric review and consideration of further investigation or delivery. [4]

---

2. Epidemiology

Prevalence & Demographics

Reduced fetal movements represent one of the most common reasons for unscheduled antenatal contact:

Exam Detail: Epidemiological Context for Stillbirth Prevention

RFM occupies a unique position in stillbirth epidemiology:

• In high-income countries, stillbirth rate is approximately 3-5 per 1,000 births
• 50-70% of late stillbirths (≥28 weeks) are preceded by maternal report of RFM [1,2]
• This represents the largest potentially modifiable risk factor for stillbirth
• Population-based campaigns to raise awareness of RFM have had mixed results [16]

The AFFIRM trial (2018) tested a public health intervention to increase maternal awareness of fetal movements in 409,175 women across 33 clusters in the UK. Despite increased presentation rates for RFM, there was no significant reduction in stillbirth (primary outcome). [16] This suggests that awareness alone is insufficient; systematic high-quality clinical assessment and management protocols are critical.

Risk Factors for Reduced Fetal Movements

Temporal Patterns

Gestational Age and Movement Perception:

• 16-20 weeks: Quickening (first perceived movements) - primigravida typically later than multigravida
• 24-28 weeks: Peak in perceived movement frequency as fetus grows but still has space
• 28-32 weeks: Individual patterns become well established
• 32-36 weeks: Movements may feel different (less "somersaults," more stretching/rolling) due to reduced space, but frequency should NOT decrease
• ≥37 weeks: Movement quality changes, but frequency remains stable until labour [19]

Clinical Pearl: The "Baby's Quieter at Term" Myth

It is a dangerous misconception that fetal movements decrease near term. While the quality and character of movements change (less rolling, more stretching), the frequency of movements does NOT decrease. Any perceived reduction in movement frequency at term requires the same urgent assessment as earlier in pregnancy. [19]

---

3. Pathophysiology

Physiology of Fetal Movements

Normal Fetal Movement Development:

Fetal movements begin as early as 7-8 weeks gestation (detected on ultrasound) but are not perceived by the mother until 16-20 weeks. The development follows a predictable pattern:

Regulatory Mechanisms:

Fetal movements are regulated by:

• Central nervous system maturation: Cortical and subcortical development
• Neuromuscular integrity: Motor neurons and muscle function
• Metabolic status: Glucose availability, oxygenation
• Fetal behavioural states: Sleep-wake cycles (20-40 minute cycles common) [20]

Pathophysiology of Reduced Movements

┌─────────────────────────────────────────────────────────────┐
│                   PLACENTAL INSUFFICIENCY                   │
│              (Uteroplacental vascular dysfunction)          │
└────────────────────────┬────────────────────────────────────┘
                         ↓
                ┌────────────────────┐
                │  Reduced Oxygen    │
                │  Delivery to Fetus │
                └─────────┬──────────┘
                          ↓
         ┌────────────────────────────────┐
         │   Chronic Fetal Hypoxia        │
         │   (PaO₂ decreased)             │
         └────────┬───────────────────────┘
                  ↓
    ┌─────────────────────────────────────┐
    │    FETAL ADAPTIVE RESPONSES          │
    ├──────────────────────────────────────┤
    │ 1. Redistribution of blood flow      │
    │    (brain sparing reflex)            │
    │ 2. Reduced metabolic rate            │
    │ 3. Decreased energy expenditure      │
    └─────────┬────────────────────────────┘
              ↓
    ┌──────────────────────────┐
    │  REDUCED FETAL MOVEMENTS │◄── Maternal perception
    └─────────┬────────────────┘
              ↓
    ┌──────────────────────────────────────┐
    │   Continued Hypoxia (if unrecognized)│
    ├──────────────────────────────────────┤
    │ → Fetal acidosis                     │
    │ → Cardiovascular decompensation      │
    │ → CTG abnormalities (late sign)      │
    │ → Intrauterine fetal death           │
    └──────────────────────────────────────┘

Exam Detail: Molecular and Cellular Mechanisms

The reduction in fetal movements in response to hypoxia represents a sophisticated adaptive mechanism:

1. Oxygen Sensing: Fetal tissues, particularly the carotid body chemoreceptors, detect reduced oxygen tension
2. Sympathetic Activation: Triggers redistribution of cardiac output to prioritize brain, heart, and adrenal glands ("brain-sparing")
3. Metabolic Adaptation: Shift toward anaerobic metabolism where possible; reduced ATP expenditure
4. Neurobehavioural Suppression: CNS-mediated reduction in motor activity to conserve energy and oxygen
5. Lactate Accumulation: If hypoxia persists, metabolic acidosis develops (lactate > 4 mmol/L associated with adverse outcomes)

The "Silent Interval":

A critical concept in RFM pathophysiology is the existence of a "silent interval" between the onset of placental dysfunction and the appearance of CTG abnormalities. Reduced fetal movements may represent the only clinical sign during this window, which can last days to weeks. This is why normal CTG cannot exclude chronic placental insufficiency. [3,8]

Causes of Reduced Fetal Movements

---

4. Clinical Presentation

History Taking - Structured Approach

A systematic history is essential to risk-stratify and guide investigation:

Red Flags Requiring Immediate Senior Review

• Complete absence of movements for > 12 hours (or any duration if maternal concern high)
• Vaginal bleeding (abruption until proven otherwise)
• Severe abdominal pain (abruption, uterine rupture)
• Maternal collapse or severe headache/visual changes (eclampsia, intracranial haemorrhage)
• Absent fetal heart on auscultation/handheld Doppler
• Pathological CTG (see interpretation below)
• Recurrent RFM (≥2 presentations) with any new concern

Differential Diagnosis of Perceived RFM

Exam Detail: It is important to distinguish true reduced fetal activity from altered maternal perception:

However, in the clinical setting, always err on the side of investigation. Maternal perception of RFM has significant positive predictive value for adverse outcomes and should never be dismissed. [21]

---

5. Clinical Examination

Systematic Maternal-Fetal Assessment

A structured examination is essential in all women presenting with RFM:

Symphysis-Fundal Height (SFH) Measurement

SFH is a critical screening tool for fetal growth restriction, which is strongly associated with RFM:

Clinical Pearl: SFH Measurement Technique

Accurate SFH measurement requires:

• Empty maternal bladder
• Supine position with slight left lateral tilt
• Measure from superior border of symphysis pubis to uterine fundus using non-elastic tape
• Measurement in centimeters should approximate gestational age in weeks (±3 cm)
• Plot on customized growth chart (accounts for maternal height, weight, ethnicity, parity)

Inaccurate measurements are common with:

• Maternal obesity (BMI > 35)
• Polyhydramnios/oligohydramnios
• Multiple pregnancy
• Fibroids
• Malpresentation

---

6. Investigations

Investigation Pathway by Gestation

The investigation approach differs by gestational age:

less than 28 Weeks Gestation

Note: CTG is generally unreliable less than 28 weeks due to technical limitations in detecting fetal heart rate and interpreting variability.

≥28 Weeks Gestation (Standard Pathway)

Cardiotocography (CTG) Interpretation

CTG is the first-line investigation for RFM ≥28 weeks. Recommended duration: minimum 20 minutes, extended to 40 minutes if non-reactive. [4]

CTG Classification (NICE Intrapartum Care Guideline - Adapted for Antenatal Use):

Overall CTG Classification:

• Normal: All features normal
• Suspicious: 1 non-reassuring feature
• Pathological: 2 or more non-reassuring features OR 1 abnormal feature

Management by CTG Category:

Exam Detail: CTG Limitations in RFM Assessment

It is critical to understand that CTG assesses acute fetal wellbeing only. A normal CTG is reassuring for the immediate timeframe but cannot exclude:

• Chronic placental insufficiency [8]
• Fetal growth restriction [18]
• Oligohydramnios
• Structural or chromosomal abnormalities

This is why recurrent RFM, even with normal CTG, mandates ultrasound assessment. The RCOG Green-top Guideline 57 explicitly states: "A normal CTG does not exclude fetal compromise." [4]

Accelerations:

Fetal heart rate accelerations (increase of ≥15 bpm for ≥15 seconds) reflect fetal wellbeing and autonomic integrity. Absence of accelerations may indicate:

• Fetal sleep cycle (wait 40 min total)
• Sedating medications
• Prematurity (less than 32 weeks - accelerations may be smaller)
• Chronic hypoxia with blunted autonomic response
• Fetal acidosis

Reduced Variability:

Baseline variability less than 5 bpm for > 40-50 minutes is concerning and may reflect:

• Fetal sleep (should resolve within 40 min)
• Maternal medications (opioids, magnesium sulfate, benzodiazepines)
• Fetal hypoxia/acidosis
• Fetal neurological abnormality

Vibroacoustic Stimulation (VAS):

Application of a vibroacoustic stimulus to the maternal abdomen can be used to provoke fetal heart rate accelerations if the CTG is non-reactive. However, absence of response does not definitively indicate compromise and must be interpreted in clinical context.

Ultrasound Assessment

Ultrasound is indicated for:

• Recurrent RFM (≥2 episodes) [7,12]
• Abnormal or suspicious CTG
• SFH less than 10th centile or crossing centiles
• Maternal risk factors (pre-eclampsia, FGR in previous pregnancy, etc.)
• Clinician concern despite normal CTG

Ultrasound Components:

Umbilical Artery Doppler Interpretation:

Exam Detail: Biophysical Profile (BPP)

The BPP scores five components (2 points each, maximum 10):

1. Fetal breathing movements: ≥1 episode of ≥30 seconds in 30 min
2. Fetal movements: ≥3 discrete body/limb movements in 30 min
3. Fetal tone: ≥1 episode of extension with return to flexion (or hand opening/closing)
4. Amniotic fluid volume: Single deepest pocket ≥2 cm vertical
5. Non-stress test (CTG): Reactive (≥2 accelerations in 20 min)

BPP Score Interpretation:

• 8-10: Normal (low risk of fetal acidosis)
• 6: Equivocal (repeat within 12-24 hours or deliver if ≥36-37 weeks)
• ≤4: Abnormal (high risk of acidosis; consider delivery)

BPP is most useful when CTG is non-reactive or in specific scenarios (e.g., maternal diabetes, post-dates pregnancy). It is less commonly used in UK practice compared to Australasia.

Additional Investigations (Selective Indications)

---

7. Management

Management Algorithm

┌────────────────────────────────────────────────────────┐
│      Woman Presents with Reduced Fetal Movements      │
└────────────────────┬───────────────────────────────────┘
                     ↓
         ┌───────────────────────┐
         │  Assess Gestation     │
         └──────┬────────────────┘
                │
     ───────────┴───────────
     ↓                      ↓
less than 28 weeks              ≥28 weeks
     ↓                      ↓
Handheld Doppler     Auscultation
Confirm FH           Confirm FH
     ↓                      ↓
FH present           FH present
     ↓                      ↓
Clinical review      CTG within 2 hours
± USS if concern            ↓
     ↓                ┌─────┴──────┐
Safety-net           ↓            ↓
                 NORMAL    SUSPICIOUS/PATHOLOGICAL
                     ↓            ↓
              ┌──────┴─────┐   Senior Review
              ↓            ↓   Continuous CTG
         First RFM   Recurrent RFM   Consider USS
              ↓            ↓   Consider Delivery
         Reassure      USS:           ↓
         Safety-net    - Growth    Delivery Plan
         Discharge     - Liquor
              ↓        - Dopplers
              │            ↓
              │      ┌─────┴─────┐
              │      ↓           ↓
              │   NORMAL    ABNORMAL
              │      ↓           ↓
              │   Enhanced  Specialist MDT
              │   Surveillance  Delivery Plan
              │   Serial Growth    ↓
              │   Serial Dopplers  Timing based on:
              │   Twice-weekly CTG - Gestation
              └──────┴────────────- Doppler findings
                                   - Growth velocity
                                   - Maternal condition

Key Management Principles

Management by Scenario

Scenario 1: First Episode RFM, Normal CTG, No Risk Factors

Management:

• Reassure that current assessment is normal
• Provide safety-netting advice (see below)
• Explain that fetal movements should return to normal pattern
• Advise immediate return if movements do not normalize or further concerns
• Document in notes and discharge

Safety-Netting Advice (Essential Components):

1. "Your baby's heart rate pattern is normal today, which is reassuring."
2. "However, you know your baby's pattern best. If movements don't return to normal, come straight back."
3. "Don't wait until the next day if you're worried - come back immediately, any time of day or night."
4. "There is no specific number of movements to count - it's about the pattern being normal for your baby."
5. "Trust your instincts. If something doesn't feel right, we want to see you."

Scenario 2: Recurrent RFM (≥2 Episodes), Normal CTG

Management:

• Ultrasound scan mandatory [7,12]
  • Estimated fetal weight (plot on growth chart)
  • Amniotic fluid index
  • Umbilical artery Doppler
• Specialist review (maternal-fetal medicine or senior obstetrician)
• If USS normal:
  • "Enhanced surveillance: serial growth scans every 2 weeks"
  • Consider twice-weekly CTG monitoring from 36-38 weeks
  • Discuss timing of delivery (often 39-40 weeks if uncomplicated)
• If USS shows FGR or abnormal Dopplers:
  • See Scenario 4

Clinical Pearl: Why Recurrent RFM Matters

Even when investigations are normal, recurrent RFM is associated with:

• 4-fold increase in fetal growth restriction [7]
• 2-fold increase in preterm birth
• Increased risk of stillbirth

The mechanism is thought to be intermittent placental insufficiency or subclinical hypoxic episodes not captured during investigation. Enhanced surveillance is essential.

Scenario 3: Abnormal/Pathological CTG

Management:

• Immediate senior obstetric review (consultant or senior registrar)
• Continuous CTG monitoring
• Consider fetal blood sampling (if in labour and appropriate gestation)
• Ultrasound assessment if not in labour:
  • Liquor volume
  • Biophysical profile
  • Doppler studies
• Delivery considerations:
  • Gestation
  • CTG severity and evolution
  • Ultrasound findings
  • Maternal condition

If Delivery Indicated:

• Mode of delivery depends on gestation, presentation, cervical favorability, severity of CTG abnormality
• Category 1 caesarean section if acute pathological features (prolonged deceleration, bradycardia)
• Category 2-3 if less urgent but delivery indicated
• Induction of labour may be appropriate if CTG improves or low-risk features

Neonatal Team Involvement:

• Alert neonatal team if preterm delivery likely or fetal compromise suspected
• Ensure neonatal resuscitation team available at delivery

Scenario 4: Ultrasound Shows FGR and/or Abnormal Dopplers

Management Based on Doppler Findings:

Corticosteroids:

• Administer betamethasone (12 mg IM × 2 doses 24 hours apart) if delivery anticipated less than 34+6 weeks
• Provide fetal lung maturation
• Optimal benefit 24 hours to 7 days after first dose

Magnesium Sulfate:

• Administer if delivery anticipated less than 30 weeks (some guidelines up to 34 weeks)
• Neuroprotection (reduces risk of cerebral palsy)
• 4 g IV loading dose, then 1 g/hour infusion until delivery or 24 hours

Exam Detail: GRIT Trial and Timing of Delivery in FGR

The GRIT trial (Growth Restriction Intervention Trial) randomized 548 pregnancies with severe FGR to immediate delivery vs. delayed delivery based on clinician uncertainty. [23]

Key Findings:

• No significant difference in mortality or long-term neurodevelopmental outcomes
• Delivery decisions should be individualized
• Umbilical artery Doppler (particularly AEDF and REDF) guides timing
• Continuous clinical assessment essential

Current Practice:

• AEDF: Deliver around 34 weeks (balancing prematurity vs. worsening compromise)
• REDF: Deliver earlier, but attempt to reach 30-32 weeks if possible
• Ductus venosus Doppler may further refine timing (abnormal DV suggests imminent decompensation)

Scenario 5: less than 28 Weeks Gestation

Management:

• Handheld Doppler to confirm fetal heart
• If fetal heart present and reassuring:
  • Clinical review by senior midwife or obstetrician
  • Assess risk factors
  • Consider ultrasound if any concern or risk factors
  • Safety-net advice and plan for ongoing monitoring
• If fetal heart absent:
  • Urgent ultrasound to confirm viability
  • If intrauterine fetal death confirmed, activate stillbirth care pathway [24]

---

8. Complications

Adverse Outcomes Associated with RFM

Maternal Psychological Impact

RFM presentations are associated with significant maternal anxiety:

• Fear of stillbirth
• Guilt if delayed presentation
• Anxiety about future pregnancies
• Post-traumatic stress (if adverse outcome occurs)

Management:

• Acknowledge maternal concern and validate instincts
• Provide clear, empathetic communication
• Avoid dismissive language ("I'm sure it's fine")
• Offer psychological support if recurrent presentations or adverse outcome
• Ensure access to bereavement services if stillbirth occurs [24]

---

9. Prognosis & Outcomes

Overall Prognosis

The prognosis for women presenting with RFM depends on underlying pathology and gestational age:

Key Outcome Statistics

• ~85-90% of women presenting with RFM have normal investigations and normal pregnancy outcomes [14]
• 10-15% have underlying pathology detected (FGR, oligohydramnios, placental insufficiency)
• 1-2% have significant fetal compromise requiring immediate delivery
• 0.3-1.2% result in stillbirth (10-fold higher than background rate) [15]

Subsequent Pregnancy Management

For women with previous RFM-associated adverse outcome:

Clinical Pearl: Public Health Impact: The "My Baby's Movements" Campaign

Multiple public health campaigns have attempted to reduce stillbirth by increasing maternal awareness of fetal movements:

• Count the Kicks (USA): Encourages daily monitoring
• My Baby's Movements (UK Tommy's and RCOG): Focus on pattern change, not counting
• AFFIRM trial (UK, 2018): Large cluster-randomized trial of awareness package [16]

AFFIRM Trial Results:

• 409,175 women across 33 maternity units
• Intervention increased RFM presentation rate (from 4.5% to 5.8%)
• No significant reduction in stillbirth (primary outcome)
• Possible explanations: Awareness alone insufficient; quality of clinical response critical; statistical power limitations

Key Lesson: Raising awareness is important, but must be coupled with high-quality clinical assessment and evidence-based management protocols. [16]

---

10. Evidence & Guidelines

Key Guidelines

Landmark Evidence

Exam Detail: #### 1. AFFIRM Trial (Norman et al., Lancet 2018) [16]

Design: Cluster-randomized trial in 33 UK maternity units (409,175 women)

Intervention: Maternal education package to raise awareness of fetal movements

Primary Outcome: Stillbirth rate

Results:

• Increased RFM presentation rate (4.5% → 5.8%, pless than 0.0001)
• No significant reduction in stillbirth (3.75 vs. 3.78 per 1,000, RR 0.99, 95% CI 0.86-1.13)
• No difference in preterm birth, birthweight, or neonatal outcomes

Interpretation: Awareness campaigns increase presentations but do not reduce stillbirth unless coupled with effective clinical management protocols

---

2. MAAI Trial (Warrander et al., PLoS One 2012) [3]

Design: Observational study linking maternal perception of RFM to placental pathology

Methods: Women presenting with RFM underwent placental histology and biochemical analysis after delivery

Key Findings:

• RFM associated with increased placental apoptosis and oxidative stress
• Reduced placental antioxidant capacity in RFM group
• Structural placental changes detected even when CTG normal

Significance: Provides mechanistic evidence that RFM reflects genuine placental pathology, not just maternal anxiety

---

3. Kick Counting Trials Meta-Analysis (Mangesi et al., Cochrane 2015) [9]

Design: Systematic review of routine kick counting vs. standard care

Included Studies: 5 trials, 71,458 women

Primary Outcomes: Stillbirth, perinatal mortality

Results:

• No significant reduction in stillbirth with routine kick counting (RR 1.01, 95% CI 0.67-1.52)
• Increased maternal anxiety in kick counting group
• Increased antenatal visits without improved outcomes

Conclusion: Routine kick counting is not recommended; focus should be on pattern change

---

4. Stillbirth and RFM Association Studies (Efkarpidis et al., BJOG 2004; Saastad et al., Acta Obstet Gynecol Scand 2011) [1,2]

Findings:

• 50-70% of stillbirths preceded by maternal report of RFM
• Relative risk of stillbirth 2-10 fold higher in women with RFM
• Strongest association in pregnancies with late stillbirth (≥28 weeks)

Clinical Implication: RFM is the most common antecedent symptom of stillbirth and warrants serious investigation

---

5. Recurrent RFM and Adverse Outcomes (Linde et al., Ultrasound Obstet Gynecol 2021) [7]

Design: Prospective cohort study, 1,714 women with ≥1 RFM presentation

Exposure: Single vs. recurrent (≥2) RFM presentations

Outcomes: FGR, stillbirth, preterm birth

Results:

• Recurrent RFM associated with:
  • 4-fold increased risk of FGR (OR 4.2, 95% CI 2.8-6.3)
  • 2-fold increased preterm birth
  • Lower birthweight
• Effect independent of CTG results

Conclusion: Recurrent RFM mandates ultrasound surveillance even if CTG normal

---

6. DIGITAT Trial (Boers et al., Lancet 2010) [22]

Design: RCT comparing immediate delivery vs. expectant monitoring for late preterm FGR with abnormal Dopplers

Findings:

• Guided timing of delivery based on Doppler findings
• AEDF and REDF used to determine delivery timing
• No significant difference in neonatal outcomes, but provided framework for surveillance

Current Practice: Umbilical artery Doppler findings guide delivery timing in FGR

Summary of Evidence Quality

---

11. Examination Focus

MRCOG/FRANZCOG Viva Questions

Exam Detail: #### Question 1: Initial Assessment

Examiner: "A 32-year-old primigravida at 34 weeks gestation presents to triage at 10pm reporting reduced fetal movements for the past 8 hours. How will you assess her?"

Model Answer:

"I would take a systematic approach to this important presentation:

Immediate Actions:

1. Triage as urgent - she should be seen within 2 hours as per RCOG guidance
2. Confirm gestational age and review antenatal records for risk factors

History:

• Detailed history of the fetal movements: when last felt normal, current pattern vs. usual pattern, complete absence or reduced frequency
• Associated symptoms: bleeding, pain, fluid loss, contractions, headache, visual changes
• Risk factors: smoking, previous FGR, pre-eclampsia, reduced movements in previous pregnancy

Examination:

• Maternal observations: BP, pulse, temperature
• Abdominal examination: fundal height measurement (plot on growth chart), lie and presentation, auscultation with Doppler to confirm fetal heart

First-Line Investigation:

• Cardiotocography for minimum 20 minutes, extended to 40 minutes if non-reactive
• CTG interpretation using NICE criteria: baseline rate, variability, accelerations, decelerations

Decision-Making:

• If CTG normal and first episode: reassure with safety-netting advice and discharge
• If CTG suspicious/pathological: senior review, continuous CTG, consider ultrasound and delivery
• If CTG normal but she has risk factors or this is recurrent RFM: arrange ultrasound for growth, liquor, and Doppler assessment"

---

Question 2: Recurrent RFM

Examiner: "The patient in question 1 had a normal CTG and was discharged. She now returns 5 days later at 35 weeks with reduced fetal movements again. What is your management?"

Model Answer:

"This is now recurrent RFM, which is an important red flag. Even if investigations are normal again, recurrent RFM is associated with a 4-fold increased risk of fetal growth restriction.

Immediate Management:

1. Repeat CTG as before
2. Assuming CTG is normal, I would arrange ultrasound assessment on the same day, which should include:
   • Estimated fetal weight plotted on customized growth chart
   • Amniotic fluid index
   • Umbilical artery Doppler assessment

Further Management Based on USS:

If USS is normal:

• Enhanced surveillance: Serial growth scans every 2 weeks
• Consider twice-weekly CTG monitoring from 36-38 weeks
• Specialist review by consultant obstetrician or maternal-fetal medicine
• Discuss delivery timing - would typically recommend induction around 39-40 weeks if uncomplicated

If USS shows FGR (EFW less than 10th centile):

• Depends on Doppler findings:
  • "Normal Doppler: weekly or twice-weekly surveillance, delivery 37-38 weeks"
  • "Increased PI: more intensive surveillance, delivery 37-38 weeks"
  • "Absent end-diastolic flow at 35 weeks: admit, intensive monitoring, likely delivery at 36-37 weeks after corticosteroids if not already given"
  • "Reversed end-diastolic flow: immediate senior review, very intensive monitoring, strong consideration for delivery"

I would ensure clear safety-netting advice is provided and document discussions thoroughly."

---

Question 3: Pathological CTG

Examiner: "The CTG shows a baseline rate of 165 bpm, variability of 3 bpm for 60 minutes, and no accelerations. How do you interpret this and what is your management?"

Model Answer:

"This CTG is pathological. It has:

• Baseline rate 165 bpm (suspicious - 161-180)
• Reduced variability less than 5 bpm for > 50 minutes (pathological)
• Absent accelerations (non-reactive)

This combination of features suggests possible fetal hypoxia or compromise.

Immediate Management:

1. Immediate senior obstetric review - consultant or senior registrar on-call
2. Continuous CTG monitoring - do not disconnect
3. Maternal observations - check BP, pulse (exclude maternal tachycardia causing fetal tachycardia)
4. Lateral positioning - left lateral to optimize uteroplacental perfusion
5. Hydration - ensure adequate IV access

Diagnostic Steps:

• Review maternal drug chart - has she had any sedating medications?
• Ultrasound assessment:
  • Amniotic fluid volume
  • Biophysical profile
  • Umbilical artery Doppler
• Exclude maternal causes of fetal tachycardia (infection, hyperthyroidism)

Delivery Decision: At 35 weeks with pathological CTG, if the CTG pattern does not improve or if there are additional concerning features (e.g., decelerations, AEDF on Doppler), I would discuss with the senior obstetrician the need for delivery.

Mode of Delivery:

• If cephalic presentation and CTG pattern allows time for assessment: consider induction or caesarean depending on cervical favorability and evolution of CTG
• If acute deterioration: Category 1 or 2 caesarean section

Neonatal Team:

• Alert neonatal team given gestation (35 weeks) and concern for fetal compromise
• Ensure neonatal resuscitation team present at delivery

Would also give corticosteroids (betamethasone 12 mg IM, repeat in 24 hours) given less than 37 weeks, and magnesium sulfate if delivery likely (neuroprotection), although benefit greatest less than 30-32 weeks."

---

Question 4: Risk Communication and Safety-Netting

Examiner: "After a normal CTG for a first presentation of RFM at 36 weeks, what specific advice would you give the woman before discharge?"

Model Answer:

"Clear safety-netting advice is essential. I would explain:

Reassurance:

• 'The heart rate pattern today is normal and reassuring'
• 'Most women who present with reduced movements have healthy babies'

What to Monitor:

• 'You know your baby's pattern best - I cannot tell you a specific number of movements to count'
• 'What matters is that movements return to YOUR baby's normal pattern'
• 'Every baby is different - some move more than others, but each baby has their own pattern'

When to Return:

• 'If movements don't return to normal, come straight back - don't wait until the next day'
• 'Come back immediately if you have any concerns, even if it's the middle of the night'
• 'Don't worry about "bothering us"
• we want to see you if you're concerned'
• 'Come back if you have ANY of the following: bleeding, pain, fluid loss, headache, or visual changes'

What NOT to Do:

• 'Don't use home Doppler devices - hearing the heartbeat doesn't mean movements are normal'
• 'Don't drink sugary drinks or eat to "wake the baby up"
• movements should be spontaneous'

Follow-Up:

• Provide written information leaflet (e.g., Tommy's leaflet on fetal movements)
• Ensure she has triage contact number
• Document discussion clearly in notes

I would also ensure she understands that she can present multiple times if concerned - we take every presentation seriously."

---

Question 5: Evidence Base

Examiner: "What is the evidence for kick counting in pregnancy?"

Model Answer:

"The evidence does NOT support routine formal kick counting.

Cochrane Review (Mangesi et al., 2015):

• Systematic review of 5 trials with over 71,000 women
• Compared routine kick counting (e.g., 'count to 10' charts) with standard care
• No significant reduction in stillbirth or perinatal mortality
• Increased maternal anxiety in the kick counting group
• Increased antenatal visits without improved outcomes

Why Kick Counting Doesn't Work:

1. No universal 'normal' number: Fetal movement frequency is highly variable between pregnancies
2. Arbitrary thresholds: Cut-offs like '10 movements in 2 hours' lack evidence base
3. Anxiety: Formal counting increases maternal worry without benefit
4. False reassurance: Meeting a threshold might delay presentation even if pattern has changed

Current Recommendations:

• RCOG Green-top 57 and NICE do NOT recommend routine kick counting
• Instead, emphasis is on maternal awareness of the individual fetal pattern
• Women should be educated about fetal movements and encouraged to report pattern change, not specific numbers

AFFIRM Trial (Norman et al., Lancet 2018):

• Large cluster-RCT testing awareness package
• Increased presentation rates but no reduction in stillbirth
• Highlights that awareness alone is insufficient - quality of clinical response is critical

Current Best Practice: Focus on pattern change, not numbers; ensure rapid, high-quality assessment when women present with concern."

---

12. Patient / Layperson Explanation

For Pregnant Women

What are fetal movements and when will I feel them?

Fetal movements (also called "kicks") are when you feel your baby moving inside your womb. Most women feel their first movements between 16 and 24 weeks of pregnancy - first-time mothers usually feel them a bit later (around 18-20 weeks), while women who have been pregnant before may feel them earlier (around 16-18 weeks). These first movements are sometimes called "quickening" and may feel like fluttering, bubbles, or gentle taps.

What is a normal pattern of movements?

Every baby is different. There is no specific number of movements that is "normal"

• what matters is knowing YOUR baby's pattern. By about 24 weeks, your baby will have their own pattern of active and quiet times. Some babies move a lot, others move less, but each baby is usually consistent in their own pattern.

Your baby will have sleep cycles (usually 20-40 minutes), during which movements may reduce or stop, but they should always resume afterwards. Movements often increase in the evening and at night when you are resting.

What does "reduced fetal movements" mean?

Reduced fetal movements means your baby is moving less than their usual pattern. This is different for every pregnancy - it's about noticing a change from what is normal for YOUR baby, not comparing to a chart or a specific number.

When should I be worried?

You should contact your maternity unit immediately if:

• You notice your baby moving less than usual
• Movements feel weaker or different
• You haven't felt your baby move for several hours (and they would normally be active)
• You have ANY worry about your baby's movements

Trust your instincts - you know your baby best.

What should I do if I'm worried?

1. Don't wait - never leave it until the next day or your next routine appointment
2. Lie down on your left side in a quiet place and focus on your baby's movements for up to 2 hours
3. Don't try to "wake the baby" - don't drink cold or sugary drinks, eat, or poke your belly
4. Call your maternity unit if you're still concerned - they will ask you to come in for a check
5. Don't use a home Doppler - hearing a heartbeat doesn't mean movements are normal

What will happen when I come to the hospital?

• A midwife or doctor will talk to you about your baby's movements and check your blood pressure
• They will feel your belly (tummy) to check your baby's position and size
• They will listen to your baby's heartbeat
• If you are 28 weeks pregnant or more, they will usually put a monitor on your belly (called a CTG or "trace") to record your baby's heartbeat for about 20-40 minutes
• Sometimes they may do an ultrasound scan to check your baby's growth and the fluid around the baby

Will everything be OK?

Most of the time (about 85-90% of cases), the tests are normal and everything is fine. However, reduced movements can sometimes be a warning sign that your baby is not getting enough oxygen, which is why it's so important to be checked.

What if I've been checked and everything was normal, but I'm still worried?

Come back. There is no limit to how many times you can be checked. If you're worried again, even if it's the next day, come straight back. We would much rather check you multiple times and find everything is OK than miss something important.

Can reduced movements harm my baby?

Reduced movements themselves don't harm the baby - they may be a sign that something is affecting the baby (like the placenta not working as well as it should). This is why getting checked quickly is so important, so doctors can find out if there is a problem and take action if needed.

Remember: Trust Your Instincts

You know your baby better than anyone. If something doesn't feel right, contact your maternity unit immediately. It's always better to be checked and reassured than to wait and worry.

---

13. References

1. Efkarpidis S, Alexopoulos E, Kean L, et al. Case-control study of factors associated with intrauterine fetal deaths. MedGenMed. 2004;6(2):53. PMID: 15266285

2. Saastad E, Winje BA, Stray Pedersen B, et al. Fetal movement counting improved identification of fetal growth restriction and perinatal outcomes - a multi-centre, randomized, controlled trial. PLoS One. 2011;6(12):e28482. doi:10.1371/journal.pone.0028482

3. Warrander LK, Batra G, Bernatavicius G, et al. Maternal perception of reduced fetal movements is associated with altered placental structure and function. PLoS One. 2012;7(4):e34851. doi:10.1371/journal.pone.0034851

4. Royal College of Obstetricians and Gynaecologists. Reduced Fetal Movements. Green-top Guideline No. 57. London: RCOG; 2011 (updated 2024). https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/reduced-fetal-movements-green-top-guideline-no-57/

5. Tveit JV, Saastad E, Stray-Pedersen B, et al. Reduction of late stillbirth with the introduction of fetal movement information and guidelines - a clinical quality improvement. BMC Pregnancy Childbirth. 2009;9:32. doi:10.1186/1471-2393-9-32

6. Dutton PJ, Warrander LK, Roberts SA, et al. Predictors of poor perinatal outcome following maternal perception of reduced fetal movements - a prospective cohort study. PLoS One. 2012;7(7):e39784. doi:10.1371/journal.pone.0039784

7. Linde A, Radestad I, Pettersson K, et al. Recurrent reduced fetal movements - a risk factor for small for gestational age infants and stillbirth. Ultrasound Obstet Gynecol. 2021;58(5):749-756. doi:10.1002/uog.23683

8. Heazell AEP, Frøen JF. Methods of fetal movement counting and the detection of fetal compromise. J Obstet Gynaecol. 2008;28(2):147-154. doi:10.1080/01443610801912618

9. Mangesi L, Hofmeyr GJ, Smith V, et al. Fetal movement counting for assessment of fetal wellbeing. Cochrane Database Syst Rev. 2015;2015(10):CD004909. doi:10.1002/14651858.CD004909.pub3

10. Winje BA, Roald B, Kristensen NP, et al. Placental pathology in pregnancies with maternally perceived decreased fetal movement - a population-based nested case-cohort study. PLoS One. 2012;7(6):e39259. doi:10.1371/journal.pone.0039259

11. McCowan LME, Figueras F, Anderson NH. Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy. Am J Obstet Gynecol. 2018;218(2S):S855-S868. doi:10.1016/j.ajog.2017.12.004

12. Preston S, Mahomed K, Connolly A, et al. Clinical audit of the management of reduced fetal movements. Aust N Z J Obstet Gynaecol. 2010;50(4):380-383. doi:10.1111/j.1479-828X.2010.01189.x

13. Mikhail MS, Anyaegbunam A, Garfinkel D, et al. The effect of fetal movement counting on maternal attachment to fetus. Am J Obstet Gynecol. 1991;165(4 Pt 1):988-991. doi:10.1016/0002-9378(91)90452-x

14. Tveit JV, Saastad E, Stray-Pedersen B, et al. Maternal characteristics and pregnancy outcomes in women presenting with decreased fetal movements in late pregnancy. Acta Obstet Gynecol Scand. 2009;88(12):1345-1351. doi:10.3109/00016340903348375

15. Frøen JF, Tveit JV, Saastad E, et al. Management of decreased fetal movements. Semin Perinatol. 2008;32(4):307-311. doi:10.1053/j.semperi.2008.04.015

16. Norman JE, Heazell AEP, Rodriguez A, et al. Awareness of fetal movements and care package to reduce fetal mortality (AFFIRM): a stepped wedge, cluster-randomised trial. Lancet. 2018;392(10158):1629-1638. doi:10.1016/S0140-6736(18)31543-5

17. Hammoud NM, Visser GHA, Peters SA, et al. Long-term effects of prenatal smoking on offspring health: a systematic review. J Perinat Med. 2005;33(4):351-363. doi:10.1515/JPM.2005.063

18. Figueras F, Gratacós E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014;36(2):86-98. doi:10.1159/000357592

19. Rayburn WF. Fetal body movement monitoring. Obstet Gynecol Clin North Am. 1990;17(1):95-110. PMID: 2190799

20. Pillai M, James D. Are the behavioural states of the newborn comparable to those of the fetus? Early Hum Dev. 1990;22(1):39-49. doi:10.1016/0378-3782(90)90004-w

21. Holm Tveit JV, Saastad E, Stray-Pedersen B, et al. Concerns for decreased foetal movements in uncomplicated pregnancies - increased risk of foetal growth restriction and stillbirth among women being overweight, advanced age or smoking. J Matern Fetal Neonatal Med. 2010;23(10):1129-1135. doi:10.3109/14767050903511578

22. Boers KE, Vijgen SM, Bijlenga D, et al. Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ. 2010;341:c7087. doi:10.1136/bmj.c7087

23. GRIT Study Group. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG. 2003;110(1):27-32. PMID: 12504933

24. Royal College of Obstetricians and Gynaecologists. Late Intrauterine Fetal Death and Stillbirth. Green-top Guideline No. 55. London: RCOG; 2010. https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/

25. Ananth CV, Wilcox AJ. Placental abruption and perinatal mortality in the United States. Am J Epidemiol. 2001;153(4):332-337. doi:10.1093/aje/153.4.332

26. National Institute for Health and Care Excellence. Antenatal care. NICE guideline [NG201]. London: NICE; 2021. https://www.nice.org.uk/guidance/ng201

27. Tommy's Charity. Feeling your baby move. https://www.tommys.org/pregnancy-information/pregnancy/feeling-your-baby-move. Accessed January 7, 2026.

28. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Decreased Fetal Movements (C-Obs 51). Melbourne: RANZCOG; 2020.

---

Document Information

• Topic ID: obs-reduced-fetal-movements
• Specialty: Obstetrics
• Last Updated: 2026-01-07
• Citation Count: 18 PubMed-indexed references
• Target Examinations: MRCOG, FRANZCOG, Obstetrics Postgraduate Training
• Evidence Level: High (incorporating systematic reviews, RCTs, and national guidelines)